Resveratrol supplementation decreases inflammation while minimizing hepatic steatosis via activation of the AMPKα-SIRT1 pathway, suppressing the nuclear factor kappa B (NF-κB) inflammatory pathway [80]. Here, SIRT1 is linked to fatty liver disease.